WFDC2 and ovarian carcinoma: The tumor markers CA-125 and HE4 were also statistically higher in patients with ovarian cancer (773.51–454.22 U/mL vs. 128.29 U/mL, p < 0.001;1708.42 pmol/L vs. 83.47 pmol/L, p = 0.009, respectively).